Antigenic challenge in the etiology of autoimmune disease in women

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Rogers, Mary A M ^a   Levine, Deborah A ^a   Blumberg, Neil ^b   Fisher, Gwenith G ^c   Kabeto, Mohammed ^a   Langa, Kenneth M ^a,c,d,e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Autoimmune disease; Gender; Infection; Parity; Transfusion

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD TRANSFUSION; BODY MASS; CELIAC DISEASE; COHORT ANALYSIS; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HEART DISEASE; HUMAN; HYPOTHYROIDISM; INFECTION; JEW; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MEDICARE; MULTIPLE SCLEROSIS; PARITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTIGENS; AUTOIMMUNE DISEASES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 84858748378     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.08.001     Document Type: Article

References (53)

1. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2(9):777-780.
2. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 1-6.
3. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243.
4. Davidson A., Diamond B. Autoimmune diseases. N Engl J Med 2001, 345:340-350.
5. Fairweather D., Rose N.R. Women and autoimmune diseases. Emerg Infect Dis 2004, 10:2005-2011.
6. Bach J.F. Infections and autoimmune diseases. J Autoimmun 2005, 25:74-80.
7. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
8. Doria A., Sarzi-Puttini P., Schoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008, 8:1-4.
9. Cooke A. Infection and autoimmunity. Blood Cells Mol Dis 2009, 42:105-107.
10. Refaai M.A., Phipps R.P., Spinelli S.L., Blumberg N. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 2011, 127:287-291.
11. Kim-Shapiro D.B., Lee J., Gladwin M.T. Storage lesion: role of red blood cell breakdown. Transfusion 2011, 51:844-851.
12. Goldstein D.R. Inflammation and transplantation tolerance. Semin Immunopathol 2011, 33:111-115.
13. Camps M., Ruckle T., Ji H., Ardissone V., Rintelen F., Shaw J., et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 2005, 11:936-943.
14. Barber D.F., Bartolome A., Hernandez C., Flores J.M., Redondo C., Fernandez-Arias C., et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 2005, 11:933-935.
15. Adams K.M., Nelson J.L. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004, 291:1127-1131.
16. Nelson J.L. Microchimerism: incidental byproduct of pregnancy or active participant in human health?. Trends Mol Med 2002, 8:109-113.
17. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
18. Famularo G., DeSimone C. Systemic sclerosis from autoimmunity to alloimmunity. South Med J 1999, 92:472-476.
19. Rust D.W., Bianchi D.W. Microchimerism in endocrime pathology. Endocr Pathol 2009, 20:11-16.
20. Lambert N.C., Stevens A.M., Tylee T.S., Erickson T.D., Furst D.E., Nelson J.L. From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann N Y Acad Sci 2001, 945:164-171.
21. Reed W., Lee T.H., Norris P.J., Utter G.H., Busch M.P. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin Hematol 2007, 44:24-31.
22. Wallace R.B., Herzog A.R. Overview of the health measures in the health and retirement study. J Hum Resour 1995, 30:S84-S107.
23. Carless P.A., Henry D.A., Carson J.L., Hebert P.P., McClelland B., Ker K. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2010, (10):CD002042.
24. Heeringa S.G., Connor J.H. Technical description of the health and retirement design 1995, Available at:, [assessed 15.06.11]. http://hrsonline.isr.umich.edu/sitedocs/userg/HRSSAMP.pdf.
25. Rothman K.J., Greenland S. Modern epidemiology 1998, Lippincott-Raven, Publishers, Philadelphia, PA. 2nd ed.
26. Nathan C. Points of control in inflammation. Nature 2002, 420(6917):846-852.
27. Marrack P., Kappler J., Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med 2001, 7(8):899-905.
28. Zandman-Goddeard G., Shoenfeld Y. Infections and SLE. Autoimmunity 2005, 38(7):473-485.
29. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007, 61:288-299.
30. Symmons D.P., Bankhead C.R., Harrison B.J., Brennan P., Barrett E.M., Scott D.G., et al. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997, 40(11):1955-1961.
31. Cerhan J.R., Saag K.G., Criswell L.A., Merlino L.A., Mikuls T.R. Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women. J Rheumatol 2002, 29(2):246-254.
32. Rogers M.A., Blumberg N., Heal J.M., Langa K.M. Utilization of blood transfusion among older adults in the United States. Transfusion 2011, 51(4):710-718.
33. Guthrie K.A., Dugowson C.E., Voigt L.F., Koepsell T.D., Nelson J.L. Does pregnancy provide vaccine-like protection against rheumatoid arthritis?. Arthritis Rheum 2010, 62(7):1842-1848.
34. Haynes L., Maue A.C. Effects of aging on T cell function. Curr Opin Immunol 2009, 21:414-417.
35. Lages C.S., Suffia I., Velilla P.A., Huang B., Warshaw G., Hildeman D.A., et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008, 181:1835-1848.
36. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007, 7(8):585-598.
37. Costantino C.M., Baecher-Allan C.M., Hafler D.A. Human regulatory T cells and autoimmunity. Eur J Immunol 2008, 38(4):921-924.
38. Gabriel S.E., Crowson C.S., O'Fallon W.M. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999, 42:415-420.
39. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36(3):182-188.
40. Ward M.M. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 2004, 13(6):713-718.
41. Cooper G.S., Bynum M.L.K., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009, 33:197-207.
42. Pearce S.H., Merriman T.R. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006, 12(2):90-98.
43. Simmonds M.J., Gough S.C. Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 2005, 71:93-113.
44. Brix T.H., Kyvik K.O., Hegedüs L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 2000, 85(2):536-539.
45. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43(1):30-37.
46. Sherer Y., Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006, 2(2):99-106.
47. Loppnow H., Werdan K., Buerke M. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun 2008, 14(2):63-87.
48. Kiechl S., Egger G., Mayr M., Wiedermann C.J., Bonora E., Oberhollenzer F., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103(8):1064-1070.
49. Corrado E., Novo S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005, 105(6):567-579.
50. Kato S., Chmielewski M., Honda H., Pecoits-Filho R., Matsuo S., Yuzawa Y., et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008, 3(5):1526-1533. Epub 2008 Aug 13.
51. Sokka T., Kautiainen H., Hannonen P., Pincus T. Changes in health assessment questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum 2006, 54(10):3113-3118.
52. Sydnor E.R., Perl T.M. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011, 24(1):141-173.
53. Waters J.H., Ness P.M. Patient blood management: a growing challenge and opportunity. Transfusion 2011, 51(5):902-903.